Strongbridge Biopharma plc·4

May 16, 4:14 PM ET

Steen Marten 4

4 · Strongbridge Biopharma plc · Filed May 16, 2019

Insider Transaction Report

Form 4
Period: 2019-05-15
Steen Marten
Director
Transactions
  • Award

    Ordinary Shares

    2019-05-15+40,00040,000 total(indirect: By HealthCap VI, L.P.)
Footnotes (2)
  • [F1]Represents a grant of restricted stock units, which vest in full on May 15, 2020, provided that the Reporting Person continues to provide service as a member of the Board continuously from the Grant Date through such one-year anniversary. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]Based on his affiliation with HealthCap VI, L.P., the Reporting Person may be deemed the beneficial owner of these securities. The Reporting Person expressly disclaims beneficial ownership over these securities except to the extent of his pecuniary interest therein.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -